OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...

(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today ...

In EMS|MC’s data, the average charge for a patient pronounced dead prior to transport is $975.55, with an average ...

Between one-off charges, administrative fees, and office visit copays, some are trying ...

Save 5% on FUT coins using my code "MattHD" at <a href="https://bit.ly/MMOexp-MattHD">https://bit.ly/MMOexp-MattHD</a> How to ...

U.S. AI-driven Diabetic Retinopathy Screening Market · GlobeNewswire Inc. The U.S. AI-driven diabetic retinopathy screening market is poised for notable growth, with projections estimating its value ...

New Caesars Casino players can choose from slots offering max payouts between 2,591x and 10,000x while maintaining 96% or ...

There’s a moment every psychiatrist recognizes. A patient sits down. You have 20 minutes. But their life is not 20 minutes wide.

The U.S. FDA granted marketing authorization for ProSense in October 2025 for use in low-risk early-stage breast cancer, specifically for women aged 70 and over or those unsuitable for surgery. Market ...

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript March 17, 2026 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.05. Operator: ...